Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM)
May 06, 2019 08:30 ET
|
Resverlogix Corp
CALGARY, Alberta, May 06, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today the recent publication of an article titled: “Multicenter Preclinical...
Liquidia Technologies Reports Third Quarter 2018 Financial Results and Provides Corporate Update
October 31, 2018 07:00 ET
|
Liquidia Technologies, Inc.
Completed enrollment of the safety portion of our Ph3 LIQ861 (INSPIRE) clinical trialTwo-week safety Ph3 LIQ861 data readout anticipated in the first quarter of 2019Dr. Stephen Bloch appointed as...
Improved Pulmonary Arterial Hypertension Mortality Risk ScoresShow Positive Impact of Ralinepag at the ISHLT 38th Annual Meeting & Scientific Sessions
April 14, 2018 08:45 ET
|
International Society for Heart & Lung Transplantation
NICE, FR, April 14, 2018 (GLOBE NEWSWIRE) -- Today at the International Society for Heart and Lung Transplantation (ISHLT) 38th Annual Meeting & Scientific Sessions, Raymond Benza, MD, FAAC,...
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Platform Specialty Products Corporation Of Upcoming Deadline
May 16, 2016 15:41 ET
|
Rigrodsky Law, P.A
WILMINGTON, Del., May 16, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you, or did you, own shares of Platform Specialty Products Corporation (NYSE:PAH)?Did you purchase your shares...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Platform Specialty Products Corporation - PAH
May 02, 2016 14:39 ET
|
The Rosen Law Firm PA
NEW YORK, May 02, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Platform Specialty Products...
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Platform Specialty Products Corporation -- PAH
March 31, 2016 17:45 ET
|
Rigrodsky Law, P.A
WILMINGTON, Del., March 31, 2016 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Do you, or did you, own shares of Platform Specialty Products Corporation (NYSE:PAH)?Did you purchase your shares...
Cardiome and SteadyMed Announce Decision for Centralized Review of Trevyent® by the European Medicines Agency
January 06, 2016 08:00 ET
|
SteadyMed Therapeutics
VANCOUVER, British Columbia and SAN RAMON, Calif., Jan. 06, 2016 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME), (TSX:COM) and SteadyMed Ltd. (Nasdaq:STDY), today announced that the...
SteadyMed Reports Recent Developments and Third Quarter 2015 Financial Results
November 12, 2015 16:05 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value...
SteadyMed to Report Recent Developments and Third Quarter 2015 Financial Results
November 05, 2015 07:30 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Nov. 5, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value diseases...
SteadyMed Announces Positive Clinical Study Results in Support of SMT-201 for the Treatment of Post Surgical Pain in the Home Setting
October 28, 2015 07:30 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value...